| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/2003 | WO2002017920A3 Use of methylphenidate compounds to enhance memory |
| 01/23/2003 | WO2002017893A3 Sgk2 and sgk3 used as diagnostic and therapeutic targets |
| 01/23/2003 | WO2002013798A3 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 01/23/2003 | WO2002009760A3 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 01/23/2003 | WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 01/23/2003 | WO2002004448A3 Methods for treatment of drug-induced peripheral neuropathy and related conditions |
| 01/23/2003 | WO2002002607A3 Acid-modified arabinogalactan protein composition |
| 01/23/2003 | WO2002000258A8 Medicinal compositions for angiogenic therapy |
| 01/23/2003 | WO2001089364A3 Hcv variants |
| 01/23/2003 | WO2001051472A9 New imidazole derivatives |
| 01/23/2003 | WO2001005805A9 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/23/2003 | US20030018984 IGF-I expression system and methods of use |
| 01/23/2003 | US20030018382 Process for improving vision |
| 01/23/2003 | US20030018371 Compositions and methods for the treatment of metabolic bone disorders and bone metastases |
| 01/23/2003 | US20030018222 Sovent extracting the dried marigold flower petals, eluting through an anion exchange resin column, diluting the eluent, crystallization; protecting lutein against deterioration, store for long time |
| 01/23/2003 | US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin |
| 01/23/2003 | US20030018199 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 01/23/2003 | US20030018197 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection |
| 01/23/2003 | US20030018196 Piperidine derivatives and process for their production |
| 01/23/2003 | US20030018194 New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents |
| 01/23/2003 | US20030018193 Beta-alanine derivatives and their use as receptor anatgonists |
| 01/23/2003 | US20030018190 Valency platform molecules comprising carbamate linkages |
| 01/23/2003 | US20030018189 Cyclic polyamines having total 9-24 members which have activity in against HIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors |
| 01/23/2003 | US20030018186 Monocyclic L-nucleosides, analogs and uses thereof |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018176 Dry acid-chitosan complexes |
| 01/23/2003 | US20030018085 Isostearic acid salts as permeation enhancers |
| 01/23/2003 | US20030018084 Beta-adrenergic blockade reversal of catabolism after severe burn |
| 01/23/2003 | US20030018083 Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine |
| 01/23/2003 | US20030018082 Alzheimer's, Huntington, Parkinson disease therapy |
| 01/23/2003 | US20030018081 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 01/23/2003 | US20030018080 N-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/23/2003 | US20030018079 Treatment |
| 01/23/2003 | US20030018078 Glaucoma treatments with reduced hyperpigmentation |
| 01/23/2003 | US20030018077 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 01/23/2003 | US20030018076 Topical and oral arginine to cause beneficial effects |
| 01/23/2003 | US20030018075 Threonine, or mixture with methionine; side effect reduction |
| 01/23/2003 | US20030018074 Antiinflammatory agents; skin disorders; topical applying |
| 01/23/2003 | US20030018073 Photochemistry releasing |
| 01/23/2003 | US20030018072 Utilization of dialkylfumarates |
| 01/23/2003 | US20030018071 Method and compositions for treating fibrotic diseases |
| 01/23/2003 | US20030018069 Administering an aliphatic acid compound |
| 01/23/2003 | US20030018068 Vanadium (IV) metallocene complexes having spermicidal activity |
| 01/23/2003 | US20030018067 Cardiovascular disorders; anticancer agents |
| 01/23/2003 | US20030018066 Administering vitamin e and selenium, or compound thereof |
| 01/23/2003 | US20030018064 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 01/23/2003 | US20030018063 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 01/23/2003 | US20030018061 Novel remedies with the use of beta 3 agonist |
| 01/23/2003 | US20030018060 Therapeutic methods and compositions involving isoflavones |
| 01/23/2003 | US20030018058 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 01/23/2003 | US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 01/23/2003 | US20030018054 Cirrhosis |
| 01/23/2003 | US20030018053 Substituted indolealkanoic acids |
| 01/23/2003 | US20030018052 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | US20030018050 Indole and 2,3-dihydroindole derivatives, their preparation and use |
| 01/23/2003 | US20030018049 Azithromycin combination for emesis control in mammals |
| 01/23/2003 | US20030018047 Central nervous system disorders; psychological disorders |
| 01/23/2003 | US20030018046 Chemokine receptor binding heterocyclic compounds |
| 01/23/2003 | US20030018044 Treatment of ocular disease |
| 01/23/2003 | US20030018043 N-methylnalorphine |
| 01/23/2003 | US20030018042 Psychological disorders; Alzheimer's disease |
| 01/23/2003 | US20030018041 Spiroindene and spiroindane compounds |
| 01/23/2003 | US20030018040 Tumor necrosis factor antagonist; side effect reduction;antiinflammatory agents |
| 01/23/2003 | US20030018039 Viricides |
| 01/23/2003 | US20030018038 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| 01/23/2003 | US20030018037 Use of PDE V inhibitors for improved fecundity in mammals |
| 01/23/2003 | US20030018036 Use of PDE V inhibitors for improved fecundity in mammals |
| 01/23/2003 | US20030018035 Central nervous system disorders |
| 01/23/2003 | US20030018034 Piperazine compounds and medicinal use thereof |
| 01/23/2003 | US20030018032 Bicyclic imidazo-3-yl-amine derivatives |
| 01/23/2003 | US20030018031 Formulations of 5HT agonists |
| 01/23/2003 | US20030018030 Antiepileptic agents |
| 01/23/2003 | US20030018028 Combination therapy for type II diabetes or Syndrome X |
| 01/23/2003 | US20030018027 Methods and pharmaceutical compositions for preventing problem behaviors of companion animals |
| 01/23/2003 | US20030018026 Preterm labor; urogenital disorders; fertility; psychological disorders |
| 01/23/2003 | US20030018024 Biphenyl vasopressin agonists |
| 01/23/2003 | US20030018022 Antiinflammatory agents; antiallergens |
| 01/23/2003 | US20030018021 Piperidine derivatives as subtype selective N-methyl-D-aspartate antagonists |
| 01/23/2003 | US20030018019 Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| 01/23/2003 | US20030018018 Mixture of ethinyl estradiol and norethindron acetate |
| 01/23/2003 | US20030018017 Method of treatment of type I diabetes |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | US20030018014 Compositions and methods for the treatment of chronic lymphocytic leukemia |
| 01/23/2003 | US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease |
| 01/23/2003 | US20030018012 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | US20030018010 Dissolving in alcohol; synthetic blood |
| 01/23/2003 | US20030018009 Adenosyl-cobalamin fortified compositions |
| 01/23/2003 | US20030018008 Synergistic mixture of adenosine antagonist and antiserotonine agent |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030018005 Autoimmune disease; antiinflammatory agents; antiallergens; rheumatic diseases; antitumor agents |
| 01/23/2003 | US20030018000 Process for producing wet ribavirin pellets |
| 01/23/2003 | US20030017999 Synergistic mixture of isovaleryl carnitine and polysaccharides |
| 01/23/2003 | US20030017998 Alzheimer's disease; Parkinson's disease |
| 01/23/2003 | US20030017997 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 01/23/2003 | US20030017995 Dialysis solutions and methods |
| 01/23/2003 | US20030017994 Reducing dosage |
| 01/23/2003 | US20030017993 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/23/2003 | US20030017986 Topical administering bactericide and permeable adjustment protein |
| 01/23/2003 | US20030017975 Immunosuppressants; activation of lipopeptide fungicides |
| 01/23/2003 | US20030017974 Side effect reduction of cancer therapy |